FDA Approves Antibacterial Treatment for Lung Disease
October 1st 2018The FDA has approved amikacin liposome inhalation suspension (Arikayce, Insmed), for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex (MAC) in a limited population of patients with the disease who do not respond to conventional treatment.
Read More
FDA Approves Antibacterial Treatment for Lung Disease Through Novel Pathway
September 29th 2018The FDA has approved amikacin liposome inhalation suspension (Arikayce, Insmed), for the treatment of lung disease caused by a group of bacteria in a limited population of patients with the disease who do not respond to conventional treatment.
Read More
FDA Approves First Treatment for Advanced Cutaneous Squamous Cell Carcinoma
September 29th 2018Officials with the FDA have approved cemiplimab-rwlc (Libtayo) for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or radiation.
Read More
Epilepsy Treatment Receives FDA Approval for Use in Children
September 29th 2018The FDA has expanded the indication of the antiepileptic drug perampanel (FYCOMPA®, Eisai) CIII for monotherapy and adjunctive use in pediatric patients aged 4 years and older for the treatment of partial-onset seizures (POS) with or without secondarily generalized seizures.
Read More
Epilepsy Drug Approved By FDA for Use in Children
September 29th 2018The FDA has expanded the indication of the antiepileptic drug perampanel (FYCOMPA, Eisai) CIII for monotherapy and adjunctive use in pediatric patients aged 4 years and older for the treatment of partial-onset seizures (POS) with or without secondarily generalized seizures.
Read More
Herbal Medicine: Catch Potential Problems in Pregnant Women Early
September 28th 2018Pregnant women take herbal and natural products (HNPs) as alternatives to prescription medications, but, HNPs have active ingredients and drug interactions that can potentially cause harm to both the mother and her baby.
Read More
FDA OKs New First-Line Treatment for Non-Small Cell Lung Cancer
September 28th 2018Dacomitinib (Vizimpro, Pfizer) is indicated for patients with non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.
Read More
Health Clinic Owner Sentenced to Prison in Compounding Pharmacy Fraud Case
September 28th 2018A Mississippi nurse practioner and former family clinic owner was sentenced to 42 months in prison and ordered to pay more than $1 million in restitution for her role in a health care benefits fraud scheme.
Read More